Haemonetics Corporation (HAE) Stock Analysis
Last updated Oct 27, 2026
Health Check
Last analyzed Oct 23, 2026
- Financial Health 75
- Profitability 75
- Business Quality 75
- Balance Sheet 55
- Cash Flow 80
Why this rating?
Health 74/100 — High Quality
Entry timing is weak right now. Quality may be fine; the setup is not.
Company overview
Haemonetics Corporation (HAE) is a Medical Devices company in the Healthcare sector. Compound Radar rates Haemonetics Corporation 74/100 (High Quality) due to high business quality, steady revenue growth, and manageable leverage.
Investment profile
- Quality High
- Growth Moderate
- Balance Sheet Adequate
- Valuation Fair
Financial highlights
Valuation
- P/E 57.68
- Forward P/E 20.77
- PEG 1.89
- EV/Revenue 4.71
Profitability
- Revenue Growth 5.6%
- Gross Margin 59.3%
- Operating Margin 17.9%
- Net Margin 7.1%
- ROE 11.2%
Financial strength
- Cash $224.52M
- Debt $1.17B
- Net Cash $-949.64M
- Free Cash Flow $260.44M
- Current Ratio 3.08
Similar companies
Peers in Medical Devices, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Globus Medical, Inc. Medical Devices GMED$80.90 82 Health 82 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Good Entry Good EntryA usable setup — not as clean as Strong Entry, but timing is not mixed or weak.
- Boston Scientific Corporation Medical Devices BSX$45.06 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Edwards Lifesciences Corporation Medical Devices EW$90.82 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Good Entry Good EntryA usable setup — not as clean as Strong Entry, but timing is not mixed or weak.
- Insulet Corporation Medical Devices PODD$149.83 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- TransMedics Group, Inc. Medical Devices TMDX$69.73 77 Health 77 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- DexCom, Inc. Medical Devices DXCM$78.56 76 Health 76 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Inspire Medical Systems, Inc. Medical Devices INSP$71.30 73 Health 73 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Stryker Corporation Medical Devices SYK$301.42 71 Health 71 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks Haemonetics Corporation (HAE).